Cargando…
Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
The development and licensing of a nonavalent human papillomavirus (HPV) vaccine has the potential to reduce morbidity and mortality from HPV-related cancers beyond that of first generation HPV vaccines. However, this benefit can only be realised if the offer of vaccination is accepted. Uptake of fi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920641/ https://www.ncbi.nlm.nih.gov/pubmed/27235782 http://dx.doi.org/10.1016/j.ejca.2016.04.014 |